Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|April 28, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 28, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 43% of total US population have received at least 1 dose
• 29.5% of total US population are fully vaccinated
• 29.5% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 38%
2. Connecticut: 37.2%
3. Vermont: 36.3%
4. New Mexico: 36%
5. Rhode Island: 35.4%
2. Connecticut: 37.2%
3. Vermont: 36.3%
4. New Mexico: 36%
5. Rhode Island: 35.4%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 210 302 confirmed cases
• 574 018 deaths
• 574 018 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 737 213
2. Texas: 2 883 059
3. Florida: 2 222 546
4. New York: 2 040 448
5. Illinois: 1 328 344
2. Texas: 2 883 059
3. Florida: 2 222 546
4. New York: 2 040 448
5. Illinois: 1 328 344
Deaths: California has the most deaths due to COVID-19 with 61 565 reported fatalities, followed by New York with 52 140, and Texas with 50 037.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 149 030 711 confirmed cases, 3 140 982 deaths, and 86 481 052 recoveries.
Advertisement
Related to this article
TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.
TMS 2026: Women exercising at least 5 days a week reported lower perimenopause symptom scores across psychological, somatic, and urogenital domains.
TMS 2026: Menopause hormone therapy was associated with greater weight loss on semaglutide, but not sustained additional benefits with tirzepatide, in a new study.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
TMS 2026: In ARIC, menopause before age 40 was linked to higher CVD and CHD risk, with insulin resistance mediating about 19% of the association.
TMS 2026: Post hoc OASIS 1 and 2 data show more women on elinzanetant reported improvement across all 8 PROMIS sleep disturbance items vs placebo at week 12.
In a pilot study of 20 midlife women with vasomotor symptoms, an AI-enabled VR program delivering CBT showed early feasibility and acceptability.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
2
Fezolinetant May Improve Depression, Anxiety Symptoms in Women With Menopausal VMS
3
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
4
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
5